148 related articles for article (PubMed ID: 33217589)
1. Comparison of Operative and Conservative Treatment for Asymptomatic Moyamoya Disease: Preliminary Experience in Small Retrospective Series.
Zeng H; Guo Y; Li Y; Yu X; Yan F; Tan X; Xu H; Peng Y; Zhuang J; Zhou H; Fu X; Wang L; Chen G
World Neurosurg; 2021 Feb; 146():e955-e960. PubMed ID: 33217589
[TBL] [Abstract][Full Text] [Related]
2. Results of Conservative Follow-up or Surgical Treatment of Moyamoya Patients Who Present without Hemorrhage, Transient Ischemic Attack, or Stroke.
Luo R; Gao F; Deng X; Zhang D; Zhang Y
World Neurosurg; 2017 Dec; 108():683-689. PubMed ID: 28927919
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
5. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Li H; Wang R; Zhang Y; Zhang D; Zhao J
World Neurosurg; 2017 Jul; 103():283-290. PubMed ID: 28366750
[TBL] [Abstract][Full Text] [Related]
7. Encephaloduroateriosynangiosis versus conservative treatment for patients with moyamoya disease at late Suzuki stage.
Ge P; Ye X; Zhang Q; Zhang D; Wang S; Zhao J
J Clin Neurosci; 2018 Apr; 50():277-280. PubMed ID: 29366619
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Bypass Surgery in Adult Moyamoya Disease by Onset Type.
Lim YC; Lee E; Song J
JAMA Netw Open; 2024 Jun; 7(6):e2415102. PubMed ID: 38842810
[TBL] [Abstract][Full Text] [Related]
9. Multiple Burr-Hole Surgery for the Treatment of Moyamoya Disease and Quasi-Moyamoya Disease in Children: Preliminary Surgical and Imaging Results.
Mirone G; Cicala D; Meucci C; d'Amico A; Santoro C; Muto M; Cinalli G
World Neurosurg; 2019 Jul; 127():e843-e855. PubMed ID: 30954732
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
11. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
[TBL] [Abstract][Full Text] [Related]
12. Stroke and Disease Progression During Long-Term Follow-Up of Patients with Moyamoya Disease Older Than 50 Years.
Sakai R; Hara S; Inaji M; Tanaka Y; Nariai T; Maehara T
World Neurosurg; 2024 Jul; 187():e898-e907. PubMed ID: 38734172
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Surgical Treatment on the Recurrent Stroke Prevention for Adult Patients With Hemorrhagic Moyamoya Disease.
Wang G; Zhang X; Feng M; Liu X; Guo F
J Craniofac Surg; 2017 Nov; 28(8):2113-2116. PubMed ID: 29088693
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.
Newman S; Boulter JH; Malcolm JG; Pradilla I; Pradilla G
World Neurosurg; 2020 Mar; 135():165-170. PubMed ID: 31790841
[TBL] [Abstract][Full Text] [Related]
15. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
16. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
[TBL] [Abstract][Full Text] [Related]
17. Pial synangiosis in patients with moyamoya younger than 2 years of age.
Jackson EM; Lin N; Manjila S; Scott RM; Smith ER
J Neurosurg Pediatr; 2014 Apr; 13(4):420-5. PubMed ID: 24527861
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Ipsilateral Stroke Prevention Between Conservative Management and Indirect Revascularization for Moyamoya Disease in a North American Cohort.
Porras JL; Yang W; Xu R; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Ahn ES; Tamargo RJ; Huang J
World Neurosurg; 2018 Feb; 110():e928-e936. PubMed ID: 29196251
[TBL] [Abstract][Full Text] [Related]
20. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
